Skip to main content
. Author manuscript; available in PMC: 2008 Jun 11.
Published in final edited form as: J Immunother. 2002;25(1):82–87. doi: 10.1097/00002371-200201000-00009

TABLE 3.

Overall clinical response to IL-2 treatment in evaluable patients

Response Brain metastases previously treated n = 27 (%) Brain metastases untreated n = 36 (%) No brain metastases n = 1003 (%)
CR 0 1 (2.8) 58 (5.8)
PR 5 (18.5) 1 (2.8) 141 (14.1)
Total 5 (18.5)* 2 (5.6) 199 (19.8)
7/63 (11.1)
*

p = NS versus no brain metastases.

p = 0.031 by Fisher’s exact test (trend toward significance) versus no brain metastases.